Total Payments
$1,554
2024 Payments
$130.18
Companies
22
Transactions
34
Medicare Patients
775
Medicare Billing
$100,158
Payment Breakdown by Category
Food & Beverage$1,106 (71.2%)
Other$250.00 (16.1%)
Education$198.00 (12.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,106 | 31 | 71.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $250.00 | 1 | 16.1% |
| Education | $198.00 | 2 | 12.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $349.00 | 2 | $0 (2022) |
| Celgene Corporation | $184.81 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $158.41 | 3 | $0 (2024) |
| Genentech USA, Inc. | $124.99 | 1 | $0 (2017) |
| Myriad Genetic Laboratories, Inc. | $123.88 | 4 | $0 (2024) |
| Incyte Corporation | $123.17 | 2 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $122.19 | 1 | $0 (2019) |
| Coherus Biosciences Inc. | $49.35 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $35.56 | 2 | $0 (2022) |
| PharmaEssentia USA Corporation | $34.84 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $130.18 | 6 | PharmaEssentia USA Corporation ($34.84) |
| 2022 | $597.93 | 18 | Alexion Pharmaceuticals, Inc. ($250.00) |
| 2021 | $129.50 | 4 | Myriad Genetic Laboratories, Inc. ($90.31) |
| 2019 | $221.19 | 2 | Merck Sharp & Dohme Corporation ($122.19) |
| 2018 | $133.07 | 1 | Celgene Corporation ($133.07) |
| 2017 | $342.62 | 3 | Genentech USA, Inc. ($124.99) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $28.17 | General |
| Category: Hematology | ||||||
| 09/11/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: CELLT | ||||||
| 09/05/2024 | Myriad Genetic Laboratories, Inc. | ENDOPREDICT (Device) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: ONCOLOGY | ||||||
| 05/11/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $34.84 | General |
| Category: Oncology | ||||||
| 05/09/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Oncology | ||||||
| 04/24/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2022 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 08/25/2022 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $24.17 | General |
| Category: Oncology | ||||||
| 08/25/2022 | Amgen Inc. | Nplate (Biological), XGEVA | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Hematology | ||||||
| 08/19/2022 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $26.96 | General |
| 08/12/2022 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Oncology | ||||||
| 07/26/2022 | Tactile Systems Technology Inc | Flexitouch Plus (Device), entre | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 07/20/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: ONCOLOGY | ||||||
| 05/26/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Oncology | ||||||
| 05/25/2022 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: ONCOLOGY | ||||||
| 05/05/2022 | Taiho Oncology, Inc. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Oncology | ||||||
| 04/29/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.80 | General |
| 04/27/2022 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Hematology | ||||||
| 04/08/2022 | Myriad Genetic Laboratories, Inc. | PreciseTumor (Device) | Food and Beverage | Cash or cash equivalent | $16.23 | General |
| Category: Tumor DNA Genetic Oncology Analysis | ||||||
| 04/07/2022 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 03/25/2022 | Taiho Oncology, Inc. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Oncology | ||||||
| 03/09/2022 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| 01/26/2022 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $23.57 | General |
| Category: Hematology | ||||||
| 01/11/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Cardio-renal | ||||||
| 12/03/2021 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $17.21 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 487 | 14,420 | $432,029 | $59,768 |
| 2022 | 7 | 233 | 517 | $88,975 | $30,815 |
| 2021 | 2 | 55 | 81 | $24,600 | $9,576 |
Total Patients
775
Total Services
15,018
Medicare Billing
$100,158
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 12 | 54 | $149,148 | $15,373 | 10.3% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 46 | 51 | $54,417 | $9,359 | 17.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 60 | $29,760 | $8,342 | 28.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $19,143 | $4,257 | 22.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 14 | 40 | $28,280 | $4,112 | 14.5% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 58 | 63 | $51,723 | $3,404 | 6.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 34 | $12,138 | $2,889 | 23.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 18 | $12,492 | $2,438 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 24 | $8,832 | $2,403 | 27.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 17 | 31 | $9,703 | $1,557 | 16.0% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2023 | 14 | 7,300 | $14,600 | $1,126 | 7.7% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 21 | 89 | $9,612 | $1,056 | 11.0% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2023 | 11 | 38 | $4,332 | $741.85 | 17.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 36 | 87 | $1,740 | $730.80 | 42.0% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 62 | 5,988 | $17,964 | $670.30 | 3.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 34 | 79 | $2,844 | $601.19 | 21.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 22 | 38 | $2,432 | $393.30 | 16.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 26 | $2,496 | $277.75 | 11.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 19 | 373 | $373.00 | $36.38 | 9.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 41 | 143 | $50,050 | $19,735 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 61 | $16,775 | $4,978 | 29.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $10,500 | $3,394 | 32.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 48 | 117 | $5,850 | $1,219 | 20.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 46 | 115 | $3,680 | $881.79 | 24.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 11 | 19 | $1,710 | $484.18 | 28.3% |
About Dr. Aena Patel, M.D
Dr. Aena Patel, M.D is a Hematology & Oncology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2014. The National Provider Identifier (NPI) number assigned to this provider is 1295152395.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aena Patel, M.D has received a total of $1,554 in payments from pharmaceutical and medical device companies, with $130.18 received in 2024. These payments were reported across 34 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,106).
As a Medicare-enrolled provider, Patel has provided services to 775 Medicare beneficiaries, totaling 15,018 services with total Medicare billing of $100,158. Data is available for 3 years (2021–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Plano, TX
- Active Since 03/26/2014
- Last Updated 04/18/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1295152395
Products in Payments
- Revlimid (Drug) $133.07
- Avastin (Biological) $124.99
- KEYTRUDA (Biological) $122.19
- SOLIRIS (Drug) $99.00
- EndoPredict (Device) $73.10
- Udenyca (Biological) $49.35
- BESREMI (Drug) $34.84
- LONSURF (Drug) $34.53
- REBLOZYL (Biological) $28.17
- MONJUVI (Drug) $24.17
- Pomalyst (Drug) $23.57
- NINLARO (Drug) $22.44
- Tavalisse (Drug) $21.83
- PADCEV (Biological) $21.65
- KISQALI (Drug) $20.82
- Flexitouch Plus (Device) $19.05
- ENHERTU (Drug) $19.04
- PLUVICTO (Drug) $18.96
- NERLYNX (Drug) $18.37
- LYNPARZA (Drug) $17.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Plano
Ruben Saez, Md, MD
Hematology & Oncology — Payments: $117,913
Hematology & Oncology $117,913
Deepna Jaiswal, D.o, D.O
Hematology & Oncology — Payments: $50,892
Hematology & Oncology $50,892
Dr. Thuy Le, M.d, M.D
Hematology & Oncology — Payments: $22,323
Hematology & Oncology $22,323
Andrew Kovoor, Md, MD
Hematology & Oncology — Payments: $13,233
Hematology & Oncology $13,233
Virginia Kinsella, Md, MD
Hematology & Oncology — Payments: $13,129
Hematology & Oncology $13,129
Dr. Wendy Mahone-Johnson, Md, MD
Hematology & Oncology — Payments: $8,818
Hematology & Oncology $8,818